Weston, MA, United States of America

Thomas T Perls

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2004.


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,453 
Other
 patents

Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Thomas T Perls: Innovator in Longevity Research

Introduction

Thomas T Perls is a notable inventor based in Weston, MA (US). He has made significant contributions to the field of genetics, particularly in understanding the factors that contribute to longevity. His work focuses on identifying genetic markers that indicate a propensity for longevity and resistance to age-related diseases.

Latest Patents

Thomas T Perls holds a patent titled "Genetic loci indicative of propensity for longevity and methods for identifying propensity for age-related disease." This invention relates to genetic loci and methods for using polymorphic markers indicative of the propensity for longevity and the resistance to age-related disease. In particular, the invention defines a specified region of human chromosome 4 associated with exceptional longevity. He has 1 patent to his name.

Career Highlights

Throughout his career, Thomas T Perls has been dedicated to advancing the understanding of genetics and its implications for health and longevity. His research has paved the way for new insights into how genetic factors can influence lifespan and the development of age-related conditions.

Collaborations

Thomas has collaborated with esteemed colleagues in his field, including Annibale A Puca and Louis M Kunkel. These collaborations have further enriched his research and contributed to the advancement of knowledge in longevity studies.

Conclusion

In summary, Thomas T Perls is a pioneering inventor whose work in genetics has significant implications for understanding longevity and age-related diseases. His contributions continue to influence the field and inspire future research.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…